Cresset Asset Management’s Veracyte VCYT Stock Holding History

Cresset Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,694	Closed	-$432K	–	2213
2024 Q3	$432K	Sell	12,694 -640	-5%	-$18K	﹤0.01%	1613
2024 Q2	$289K	Buy	13,334 +396	+3%	+$8.33K	﹤0.01%	1738
2024 Q1	$287K	Sell	12,938 -217	-2%	-$5.29K	﹤0.01%	1610
2023 Q4	$362K	Sell	13,155 -1,074	-8%	-$25.9K	﹤0.01%	1402
2023 Q3	$318K	Buy	14,229 +2,573	+22%	+$66.2K	﹤0.01%	1419
2023 Q2	$297K	Buy	+11,656	New	+$283K	﹤0.01%	1523
2021 Q2	–	Sell	-8,513	Closed	-$457K	–	1084
2021 Q1	$457K	Buy	+8,513	New	+$490K	0.01%	511

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Cresset Asset Management's VCYT Position: Q4 2024 in Review

Cresset Asset Management sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 12,694 shares — an estimated $432K sold.

Cresset Asset Management first reported a position in VCYT in Q1 2021 and held it in 7 quarters. The position peaked at $457K in Q1 2021. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

Cresset Asset Management reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
Cresset Asset Management sold 12,694 Veracyte shares in Q4 2024, an estimated $432K.
Cresset Asset Management first reported a position in Veracyte in Q1 2021 and held it in 7 quarters.
Cresset Asset Management's Veracyte position peaked at $457K in Q1 2021.
318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.